Disease | arthropathy |
Phenotype | C0019069|hemophilia |
Sentences | 6 |
PubMedID- 19943875 | Background: prophylactic factor (f)viii has been shown to reduce bleeds and arthropathy in patients with severe hemophilia a. |
PubMedID- 23906463 | [long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in china: a single-center observation study]. |
PubMedID- 24022804 | arthropathy in patients with moderate hemophilia a: a systematic review of the literature. |
PubMedID- 21255253 | Conclusion: this randomized trial confirms the efficacy of prophylaxis in preventing bleeds and arthropathy in children with hemophilia, particularly when it is initiated early in life. |
PubMedID- 21922352 | To prevent joint bleedings and thus arthropathy in patients with severe hemophilia, prophylactic treatment with clotting factor concentrate is mostly indicated [13]. |
PubMedID- 22778972 | This randomized trial confirmed the efficacy of prophylaxis in preventing bleeds and arthropathy in children with hemophilia, particularly when it is initiated early in life. |
Page: 1